Federal seizure surgery data from 2022–2023 meta-analyses show that 60–75% of children with Sturge-Weber syndrome who undergo focal lesionectomy become seizure-free or have >90% seizure reduction. The best outcomes occur in infants under 2 years old with unilateral (one-sided) cortical involvement. Surgery is considered when a child has tried ≥2 anti-seizure medications at full doses for 3+ months without adequate control. Pre-operative workup includes fMRI (functional brain imaging to map safe zones), intracranial EEG (electrodes placed directly on the brain to pinpoint the seizure source), and neuropsychological testing [5][6][7].
The biological reason surgery works is that it removes the 'electrical hot spot'—the scarred, abnormal vascular tissue that triggers seizures. By removing this damaged zone before age 2, doctors prevent years of repeated seizures that would otherwise damage the developing brain. Early surgery (before age 2) also allows the brain to reorganize and recover function better than surgery in older children. Developmental gains (improved speech, motor skills, learning) become visible within 12–24 months after successful surgery [5][7][8].
Real-world costs and timing: focal lesionectomy costs $50,000–150,000 (usually covered by insurance); pre-operative workup (fMRI, intracranial EEG, neuropsych testing) costs $10,000–20,000. Hospital stay is 3–7 days. Risks include infection (1–2%), bleeding (1–3%), and temporary weakness (5–10%), but serious permanent disability is rare (<2%). Waiting for surgery costs families years of uncontrolled seizures, school absences, and developmental delay [5][6][7].